General Information
Revision date
2013-01-16
Product name
Bondesil-C18 OH
CAS No.
112926-00-8
Emergency telephone
1-800-424-9300
Icons in SDS
Company Information
company name
Agilent Technologies, Inc
Section 2
SECTION 2: Hazards identification
29 CFR 1910.1200) Physical state Solid. [Powder.] Odor : Odorless. OSHA/HCS status : While this material is not considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200), this MSDS contains valuable information critical to the safe handling and proper use of the product. This MSDS should be retained and available for employees and other users of this product. Emergency overview
Hazard statements
NOT EXPECTED TO PRODUCE SIGNIFICANT ADVERSE HEALTH EFFECTS WHEN THE RECOMMENDED INSTRUCTIONS FOR USE ARE FOLLOWED.
Precautionary statements
Keep away from heat, sparks and flame. Prevent dust accumulation. Avoid breathing dust. Use only with adequate ventilation. Keep container tightly closed and sealed until ready for use.
Principle Routes of Exposure
Inhalation.
Potential Acute Health Effects
Inhalation Exposure to airborne concentrations above statutory or recommended exposure limits may cause irritation of the nose, throat and lungs. Ingestion No known significant effects or critical hazards. Skin No known significant effects or critical hazards. Eyes Exposure to airborne concentrations above statutory or recommended exposure limits may cause irritation of the eyes.
Potential chronic health
effects : Repeated or prolonged inhalation of dust may lead to chronic respiratory irritation. Carcinogenicity : No known significant effects or critical hazards. Mutagenicity : No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects : No known significant effects or critical hazards. Fertility effects : No known significant effects or critical hazards. Over-exposure signs/symptoms Inhalation : Adverse symptoms may include the following: respiratory tract irritation coughing Ingestion : No specific data. Skin : No specific data. Eyes : Adverse symptoms may include the following: irritation redness Medical conditions : None known. aggravated by over- exposure See toxicological information (Section 11)
